이플라스크

LEADERSHIP

HOME
ABOUT US
LEADERSHIP

LEADERSHIP

Chief Executive Officer
Kyung Koo KANG, DVM., Ph.D.
- Director of Dong-A ST Research Institute
- Head of Drug Evaluation Department/ Research Planning and Management Department/ Drug Discovery Team
- Worked over 20 years in the field of new drug R&D from early discovery to IND
- Experiences of Multiple therapeutic areas and licensing in/out
Chief Scientific Officer
SeungKyoo SEONG, DVM., Ph.D.
- Head of Dong Wha Pharmaceuticals’ Pharmacology & Toxicity Lab
- Project Lead for numerous projects including national and collaborative
- More than 20 years experience in preclinical development at various disease target drugs
- Bachelor (Veterinary Medicine) and Ph.D. (Veterinary Pathology) at Seoul National University
Chief Chemistry Officer
Chang-yong, SHIN, M.S.
- Chief Researcher at Dong-A ST in Pharmaceutical Product Research Laboratories
- Experiences for 20 years in NCE, IMD and Generics development including licensing outs
- Involved in multiple roles such as API’s preparation, process development, CMC and approval
- Bachelor (Chemistry) and M.S. (Organic Chemistry) at Hankuk University of Foreign Studies
Chief Business Development Officer
Jihyun LEE, M.S.
- Chief Manager at Shin Poong Pharm.co.,Ltd, Korea University Medical Center, Korea University Medical Center Holdings and Warwick Science Park
- Conducted in global and domestic licensing, acquisitions and developing strategic partnerships
- Multiple hands-on experiences of business development from due diligence into business strategy
- M.Phil. (Biomedical Science) at University of Queensland and M.Sc. (Biotechnology Business Management) at Warwick University